Company Description
Waters Corporation provides analytical workflow solutions in Asia, the Americas, and Europe.
It operates through two segments: Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
It also designs, manufactures, sells, and services thermal analysis, rheometry, and calorimetry instruments; and develops and supplies software-based products that interface with its instruments, as well as other manufacturers' instruments.
In addition, the company offers MS technology instruments are used in drug discovery and development comprising clinical trial testing, the analysis of proteins in disease processes, nutritional safety analysis, and environmental testing.
Further, the company provides thermal analysis, rheometry, and calorimetry instruments for use in predicting the suitability and stability of fine chemicals, pharmaceuticals, water, polymers, metals, and viscous liquids for various industrial, consumer good, and healthcare products, as well as for life science research.
Its products are used by clinical, pharmaceutical, biochemical, industrial, nutritional safety, environmental, academic, and governmental customers working in research and development, quality assurance, and other laboratory applications.
The company was founded in 1958 and is headquartered in Milford, Massachusetts.
| Country | United States |
| Founded | 1958 |
| IPO Date | Nov 16, 1995 |
| Industry | Diagnostics & Research |
| Sector | Healthcare |
| Employees | 7,900 |
| CEO | Udit Batra |
Contact Details
Address: 34 Maple Street Milford, Massachusetts 01757 United States | |
| Phone | 508 478 2000 |
| Website | waters.com |
Stock Details
| Ticker Symbol | WAT |
| Exchange | NYSE |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001000697 |
| CUSIP Number | 941848103 |
| ISIN Number | US9418481035 |
| Employer ID | 13-3668640 |
| SIC Code | 3826 |
Key Executives
| Name | Position |
|---|---|
| Dr. Udit Batra Ph.D. | President, Chief Executive Officer and Director |
| Amol Chaubal | Senior Vice President and Chief Financial Officer |
| Jianqing Y. Bennett | Senior Vice President of TA Instruments Division and Waters Clinical Business Unit |
| Christos Ross | Senior Vice President of Global Operations |
| Caspar Tudor | Director of Investor Relations |
| Keeley A. Aleman | Senior Vice President, General Counsel and Corporate Secretary |
| Kristen Garvey | Vice President of Corporate Communications |
| Patrick Conway | Interim Vice President of Human Resources |
| Dr. Daniel Rush Ph.D. | Senior Vice President of Strategy and Transformation |
| Robert L. Carpio III | Senior Vice President of Waters Division |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 1, 2024 | 8-K/A | [Amend] Current report |
| Nov 1, 2024 | 10-Q | Quarterly Report |
| Nov 1, 2024 | 8-K | Current Report |
| Aug 14, 2024 | 8-K | Current Report |
| Jul 31, 2024 | 10-Q | Quarterly Report |
| Jul 31, 2024 | 8-K | Current Report |
| Jul 18, 2024 | 8-K | Current Report |
| Jun 20, 2024 | 11-K | Annual report of employee stock purchase, savings and similar plans |
| Jun 10, 2024 | SC 13G/A | [Amend] Statement of acquisition of beneficial ownership by individuals |
| May 28, 2024 | SD | Form - SD |